26,27 Other notable transcriptional differences in EGFRvIII-containing samples include increased HDAC6 expression, reported to promote glioma proliferation; increased expression of the stem cell marker SOX9; and increased expression of tumor suppressor TSC2. The gene discussed is SOX9; the disease is central nervous system cancer.